Ion pump gives the body its own pain alleviation

May 11, 2015
Credit: Linköping Universitet

A small ion pump in organic electronics is giving new hope to people suffering from severe nerve pain. Researchers at Swedish Linköping University (LiU) and Karolinska Institutet (KI) are the first in the world with technology that can stop pain impulses in living, freely moving rats using the body's own pain relief signals.

The results of ten years of research are now being published in Science Advances.

The implantable "ion pump" that delivers the body's own pain alleviators with exact dosage precisely to the location where the pain signals reach the spinal cord for further transmission to the brain, could be in clinical use in five to ten years. Firstly, the device gives hope to the seven percent of the world's population suffering from nerve pain for whom no other cure has been found - until now. But the pump could also be used to supply therapeutic substances to the brain and other parts of the body in addition to the spinal cord.

"The ion pump can be likened to a pacemaker, except for alleviating pain," says Professor Magnus Berggren, head of the research conducted by Assistant Professor Daniel Simon and PhD student Amanda Jonsson at the Laboratory of Organic Electronics at Linköping University's Campus Norrköping, in collaboration with Dr. Zhiyang Song of the Department of Clinical Neuroscience at Karolinska Institutet, where Professor Bengt Linderoth leads the preclinical side of the project.

While a pacemaker sends electrical impulses to the heart, the ion pump sends out the body's own pain alleviator – charged molecules of what are known as neurotransmitters – to the exact place where the damaged nerves come into contact with the spinal cord. This means that the pain impulses never reach the brain. In this case, the device delivered the neurotransmitter γ-aminobutyric acid (GABA), whose natural task is to inhibit stimuli in our central nervous system.

The technological breakthrough described in the Science Advances article is that the researchers constructed the therapeutic implant using – a class of materials capable of easy translation between electronic and biochemical signals –and that it has been used to block in awake, freely-moving rats. With the help of the ion pump, positively-charged ions can be administered in four different locations, adapted according to the exact points where the nerve endings meet the spinal cord. An electric current through the ion pump is all that is needed for the GABA neurotransmitter to be spread as a thin cloud at these exact locations on the . So far, the alleviation has had no negative side effects.

"What's unique is that we're using organic electronics to send the body's own chemical signals. The organic materials are easily accepted by the body, and they communicate just as in biology – with charged ions," says Assistant Professor Simon, who was also the one who presented the initial results in which an ion pump based on plastic electronics could regulate cell functions in living animals, published in Nature Materials in 2009.

Experiments on animals are strictly regulated. In this case they were conducted by researchers at the Karolinska Institute. The regulations for this type of medical advance mean that experiments on animals, for the present, are a must if the technology is to be tested on humans in the future.

In Science Advances, a new sister publication of the respected journal Science, all articles are published with open access.

Explore further: Brain chemical may offer new clues in treating chronic pain

More information: Therapy using implanted organic bioelectronics, Science Advances, advances.sciencemag.org/content/1/4/e1500039

Related Stories

Brain chemical may offer new clues in treating chronic pain

May 6, 2015
A chemical in the brain typically associated with cognition, movement and reward-motivation behavior—among others—may also play a role in promoting chronic pain, according to new research at The University of Texas at ...

Researchers show that A3 adenosine receptor can activate 'off signals' for pain

April 16, 2015
In a study published in the April issue of the Journal of Neuroscience, Saint Louis University scientists led by professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D., discovered that drugs targeting ...

Spinal cord neurons that control pain and itch

March 19, 2015
The spinal cord transmits pain signals to the brain, where they are consciously perceived. But not all the impulses arrive at their destination: Certain neurons act as checkpoints and determine whether a pain signal is relayed ...

New discovery could impact the study of chronic pain conditions

April 22, 2015
Researchers at the IRCM led by Artur Kania, PhD, uncovered the critical role in pain processing of a gene associated with a rare disease. Their breakthrough, published in The Journal of Neuroscience, paves the way for a better ...

Relieving chronic pain

March 25, 2013
A new, implantable device for treating chronic pain passes an important safety test.

Scientists chart spinal circuitry responsible for chronic pain

December 5, 2014
Pain typically has a clear cause–but not always. When a person touches something hot or bumps into a sharp object, it's no surprise that it hurts. But for people with certain chronic pain disorders, including fibromyalgia ...

Recommended for you

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.